Rick Franklin
Directeur Général chez PATHFINDER CELL THERAPY, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Joerg Gruber | M | 63 |
Pathfinder LLC
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation.
DMS Data Systems LLC
DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions.
Tarix Orphan LLC
Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | 17 ans |
John Benson | M | 62 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ
Pathfinder LLC
| 18 ans |
Gregg Lapointe | M | 65 | 9 ans | |
Timothy Walbert | M | 57 | 12 ans | |
Kim Lee | M | - | 10 ans | |
Paul Hoelscher | M | 59 | 8 ans | |
Niclas Stiernholm | M | - |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | - |
David Happel | M | 62 | 10 ans | |
Thomas Hughes | M | 64 |
Constant Therapeutics LLC
| 1 ans |
Alex Shlyankevich | M | 63 |
Constant Therapeutics LLC
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kim Tsuchimoto | F | 61 | - | |
Julie Smith | F | 53 | - | |
Michael Patrick Smith | M | 55 | 1 ans | |
Christopher Starr | M | 71 | 7 ans | |
Robert P. Hickey | M | 78 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 ans |
Georgia Erbez | F | 57 | 2 ans | |
Llew Keltner | M | 74 | 7 ans | |
Erich Sager | M | 66 | 6 ans | |
Paul K. Ross | M | - | - | |
Frank Lanza | M | 62 | - | |
Zen Chu | M | 52 |
Pathfinder LLC
| - |
John Y. Freeman | M | - |
Tucker Anthony, Inc.
| 2 ans |
Brock Reeve | M | 67 |
Pathfinder LLC
| - |
John Brooks | M | 73 |
Pathfinder LLC
| - |
Vijay Samant | M | 77 | 3 ans | |
Ashley C. Gould | F | 49 | - | |
John Alam | M | 62 |
Pathfinder LLC
| - |
Georges Gemayel | M | 64 | 1 ans | |
Suzanne Bruhn | M | 60 | 5 ans | |
Raymond Anderson | M | 82 | 7 ans | |
Michael DesJardin | M | 66 | 1 ans | |
Christine Murray | F | 63 | 2 ans | |
Marc R. Sportsman | M | 69 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 2 ans |
Henk Doude van Troostwijk | M | - | - | |
Michael Marini | M | - |
DMS Data Systems LLC
DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions. | - |
Krishna R. Polu | M | 50 | 1 ans | |
Eli Pines | M | 78 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 ans |
Todd C. Zankel | M | 60 | - | |
Robert Coffey | M | - |
DMS Data Systems LLC
DMS Data Systems LLC Miscellaneous Commercial ServicesCommercial Services DMS Data Systems is an information company focused on providing data resources to companies and organizations around the globe that work in the biomedical industry and related fields. DMS products and services include the development of online subscription databases, website content monitoring, and data feeds. The DMS Data Center database provides flexible, time saving methods for identifying, monitoring, and capturing critical industry information to make more informed business decisions. | - |
John S. Hoffer | M | - |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 6 ans |
Thomas E. Daley | M | 61 | 6 ans | |
Patricia Donahue | F | - | - | |
Corinne Mundin | F | - |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 3 ans |
Patrice Rioux | M | 73 | - | |
Brett Scott | M | 73 | - | |
Marc Patrick Reichenberger | M | 59 | - | |
Craig Johnson | M | 62 | 1 ans | |
Didier Cowling | M | 59 |
Phairson Medical Ltd.
Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | 4 ans |
Patrick John Banks | M | 62 |
Phairson Medical Ltd.
Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | 5 ans |
Barry Frankel | M | 73 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 ans |
Walter R. Maupay | M | 84 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 ans |
David Allan | M | 82 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 ans |
Justin Ford | M | - | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 51 | 96,23% |
Royaume-Uni | 2 | 3,77% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Rick Franklin
- Réseau Personnel